Vinfen
5
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
50%
2 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings
Role: collaborator
Peer-delivered and Technology-Assisted Integrated Illness Management and Recovery
Role: collaborator
Effectiveness of Interventions to Improve Resiliency & Burnout in Behavioral Health Residential Staff
Role: collaborator
Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness
Role: collaborator
The Appeal and Impact of E-cigarettes in Smokers With SMI
Role: collaborator
All 5 trials loaded